Early studies helped us to understand the benefit of early diagnosis through newborn screening for CF. This session will help further our knowledge & understand what happens to these patients after the newborn screen is positive.
Compare differences in outcomes for patients diagnosed early versus late in the era of newborn screening.
Identify the characteristics in early life for infants, such as nutritional status, including pancreatic supplementation practices & hematologic & chemical laboratory outcomes.
Describe the outcomes for patients with specifc special outcomes, such as CRMS & polyT/TG repeats.